Veterinary Medicines

Versican Plus P lyophilisate and solvent for suspension for injection for dogs

Authorised
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Download as PDF

Product identification

Medicine name:
Versican Plus P lyophilisate and solvent for suspension for injection for dogs
VERSICAN PLUS P
Active substance:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    19953.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Italia S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104899
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0265/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 24/05/2023
Download
Italian (PDF)
Published on: 10/08/2023
Download

2613561-paren-20251101.pdf

English (PDF)
Published on: 27/11/2025
Download